Compare IMUX & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMUX | QUCY |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | Germany |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.2M | 86.6M |
| IPO Year | 2013 | 2021 |
| Metric | IMUX | QUCY |
|---|---|---|
| Price | $7.73 | $0.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $43.09 | N/A |
| AVG Volume (30 Days) | 261.3K | ★ 348.4K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.00 | ★ 87.68 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $537,080.00 |
| Revenue This Year | N/A | $281.69 |
| Revenue Next Year | N/A | $123.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $0.30 |
| 52 Week High | $17.43 | $4.93 |
| Indicator | IMUX | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 45.43 | 32.54 |
| Support Level | $6.35 | $0.42 |
| Resistance Level | $8.41 | $0.69 |
| Average True Range (ATR) | 0.54 | 0.09 |
| MACD | 0.16 | -0.01 |
| Stochastic Oscillator | 43.70 | 21.63 |
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.